title: Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm.
authors.affiliation: Division of Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.|Department of Stem Cell Transplantation, Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, Texas, USA.
authors.forename: Matthew L
authors.identifier: http://orcid.org/0000-0002-1458-7813
authors.initials: ML
authors.lastname: Ulrickson
authors.affiliation: Department of Medicine, Banner University Medical Center, Phoenix, Arizona, USA.
authors.forename: Akshjot
authors.initials: A
authors.lastname: Puri
authors.affiliation: Division of Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
authors.forename: Sarah
authors.identifier: http://orcid.org/0000-0002-1406-3892
authors.initials: S
authors.lastname: Lindstrom
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.|Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA.
authors.forename: Ryan D
authors.initials: RD
authors.lastname: Cassaday
authors.affiliation: Division of Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
authors.forename: Nicolas
authors.initials: N
authors.lastname: De Padova
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.|Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Becker
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003713:Dendritic Cells; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018572:Disease-Free Survival; D000077143:Docetaxel; D005260:Female; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D043823:Taxoids / Q000008:administration & dosage; D000093542:Gemcitabine
chemical_list: D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000093542:Gemcitabine